From: Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?
 | Controls | Graves' disease Months after diagnosis | Hashimoto's thyroiditis | |||
---|---|---|---|---|---|---|
Study points (months) |  | Baseline | 3 | 18 ± 3 | 36 ± 3 |  |
Number | 19 | 32 | 18 | |||
PTH¤ (pg/ml) | 39 | 23NS | 32* | 39* | - | 32 NS |
 | (22-72) | (16-34) | (22-46) | (25-59) |  | (13-83) |
Calcium (mmol/L) | 2.23 | 2.42## | 2.30** | 2.27** | 2.31** | 2.23 NS |
 | (2.19-2.28) | (2.38-2.46) | (2.27-2.34) | (2.24-2.29) | (2.28-2.35) | (2.24-2.35) |
Ca2+ (mmol/L) | 1.21 | 1.32## | 1.23** | 1.24** | 1.25** | 1.26 NS |
 | (1.20-1.23) | (1.31-1.34) | (1.22-1.26) | (1.23-1.25) | (1.23-1.26) | (1.16-1.38) |
Alkaline phosphatase | 136 | 223## | 251## | 180**,# | 160** | 150NS |
(U/I) | (120-155) | (199-249) | (218-288) | (159-204) | (141-180) | (126-179) |
Urinary Calcium (mmol) | 4.1 | 5.2NS | 2.8** | 3.6 NS | 4.0 NS | 3.4 NS |
 | (2.9-5.9) | (4.1-6.5) | (2.2-3.7) | (2.9-4.5) | (3.1-5.2) | (2.6-4.5) |
Creatinine Cl. (ml/sec) | 1.3 | 1.2NS | 1.3NS | 1.2 NS | 1.3 NS | 1.1 NS |
 | (1.2-1.5) | (1.1-1.4) | (1.2-1.4) | (1.1-1.4) | (1.1-1.5) | (1.0-2.3) |